Skip to search formSkip to main contentSkip to account menu

Diquafosol

Known as: diuridine 5'-(pentahydrogen tetraphosphate) tetrasodium salt 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ABSTRACT Purpose: To evaluate the immediate effect of 3% diquafosol ophthalmic solution on tear MUC5AC concentration, periodic… 
2017
2017
Purpose To evaluate changes in the tear meniscus area and tear meniscus height over time in patients with dry eye syndrome, using… 
2016
2016
Abstract: Tear fluids are a mixture of secretions derived from lacrimal glands, accessory lacrimal glands, conjunctiva, and… 
2016
2016
Purpose: To evaluate the immediate effects of 3% diquafosol ophthalmic solution on tear MUC5AC concentration and corneal wetting… 
2015
2015
PurposeTo evaluate the clinical efficacy of 3 % diquafosol sodium ophthalmic solution for dry eye, and to analyze the… 
2014
2014
Purpose To investigate the role of a water and mucin secretagogue (3% diquafosol sodium eye drops) on the tear function and… 
2014
2014
Introduction: This study was designed to evaluate the efficacy and safety of 3% diquafosol ophthalmic solution in dry eye… 
2014
2014
Zwischen 10 und 20% der erwachsenen Bevolkerung Mitteleuropas leiden laut Experten an Keratokonjunktivitis sicca, dem trockenen… 
2007
2007
At present, there is no treatment capable of modifying the evolution of Sjögren’s syndrome (SS) and the therapeutic approach is… 
Review
2005
Review
2005
Sjögren’s syndrome (SS) is an autoimmune disorder, the principal ocular manifestation of which is decreased tear production…